Prelude Therapeutics Ownership | Who Owns Prelude Therapeutics?
Prelude Therapeutics Ownership Summary
Prelude Therapeutics is owned by 52.96% institutional investors, 13.76% insiders, and 33.28% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.18% of PRLD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.90% of its assets in Prelude Therapeutics shares.
PRLD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Prelude Therapeutics | 52.96% | 13.76% | 33.28% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 14.18% | $37.31M |
| Baker bros. advisors lp | 10.12M | 13.16% | $34.62M |
| Boxer capital | 2.57M | 3.39% | $9.79M |
| Affinity asset advisors | 2.60M | 2.64% | $10.17M |
| Kynam capital management, lp | 1.59M | 2.07% | $5.45M |
| Vanguard capital management | 1.90M | 1.93% | $7.42M |
| Blackrock funding, inc. /de | 1.86M | 1.89% | $7.26M |
| Vanguard group | 1.41M | 1.86% | $4.10M |
| Blackrock | 1.07M | 1.41% | $4.07M |
| Two sigma investments, lp | 923.63K | 1.20% | $3.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 0.74% | $37.31M |
| Boxer capital | 2.57M | 0.52% | $9.79M |
| Affinity asset advisors | 2.60M | 0.41% | $10.17M |
| Kynam capital management, lp | 1.59M | 0.34% | $5.45M |
| Sphera funds management | 558.34K | 0.30% | $1.91M |
| Baker bros. advisors lp | 10.12M | 0.20% | $34.62M |
| Spark investment management | 20.40K | 0.13% | $79.76K |
| Integrated quantitative investments | 60.68K | 0.04% | $237.25K |
| Entrypoint capital | 16.46K | 0.02% | $64.34K |
| Shay capital | 100.00K | 0.01% | $144.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Affinity asset advisors | 2.60M | 0.41% | 2.60M |
| Kynam capital management, lp | 1.59M | 0.34% | 803.68K |
| Sphera funds management | 558.34K | 0.30% | 435.59K |
| Vanguard group | 1.41M | 0.00% | 421.13K |
| Ubs group | 556.53K | 0.00% | 237.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -3.77M |
| Ecor1 capital | - | - | -947.05K |
| Exoduspoint capital management, lp | - | - | -921.62K |
| Avidity partners management lp | - | - | -890.00K |
| Price t rowe associates inc /md/ | - | - | -755.96K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Affinity asset advisors | 2.60M | 0.41% | 2.60M | $10.17M |
| Citadel advisors | 124.38K | 0.00% | 124.38K | $425.37K |
| Arrowstreet capital, limited partnership | 106.74K | 0.00% | 106.74K | $417.36K |
| Integrated quantitative investments | 60.68K | 0.04% | 60.68K | $237.25K |
| Empowered funds | 59.98K | 0.00% | 59.98K | $234.51K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -1.00 |
| Ifp advisors | -1.00 |
| Capital performance advisors llp | -8.00 |
| True wealth design | -13.00 |
| Highmark wealth management | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 90 | 8.43% | 52,108,026 | 4.91% | 52 | 2.08% | 50 | -19.35% | 24 | 166.67% |
| Jun 30, 2026 | 83 | 48.21% | 49,667,034 | 61.40% | 50 | 3.63% | 62 | 93.75% | 9 | -25.00% |
| Mar 31, 2026 | 13 | -73.47% | 1,621,555 | -94.30% | 2 | 0.15% | 8 | -66.67% | 2 | -86.67% |
| Dec 31, 2025 | 26 | -42.22% | 4,054,360 | -85.07% | 5 | 0.42% | 12 | -20.00% | 9 | -52.63% |
| Sep 30, 2025 | 44 | -2.22% | 27,161,948 | 1.82% | 35 | 2.90% | 15 | -11.76% | 18 | -14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.51M | 1.90% | 577.82K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.51M | 1.90% | 577.82K |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.51M | 1.90% | - |
| Vanguard US Total Market Shares ETF | 720.43K | 1.31% | - |
| iShares Russell 2000 ETF | 691.97K | 0.87% | - |
| T. Rowe Price Health Sciences | 516.22K | 0.82% | -40.53K |
| MFS New Discovery I | 327.70K | 0.60% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 458.36K | 0.57% | - |
| Biotech Growth Ord | 346.50K | 0.43% | - |
| Fidelity Small Cap Index | 303.52K | 0.38% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 21, 2026 | Bonita David P | Buy | $7.50M | |
| Apr 21, 2026 | Bonita David P | Buy | $5.00M | |
| Apr 21, 2026 | ORBIMED ADVISORS LLC | Buy | $5.00M | |
| Apr 21, 2026 | ORBIMED ADVISORS LLC | Buy | $7.50M | |
| Apr 21, 2026 | BAKER BROS. ADVISORS LP | Buy | $213.77 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 6 | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
PRLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools